PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 18 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A systematic review of mescaline (the primary alkaloid in San Pedro) reported therapeutic effects including improvements in depression scales, well-being, nicotine dependence, alcohol use, and obsessions [PMID:41977267].
A single case study involving a 35-year-old female reported substantial reductions in depression and changes in subjective connectedness following Huachuma (San Pedro) ceremonies [PMID:41647444].
Evidence summary
PubMed sources
- 1.PMID: 29847089 (2018) — Dark Classics in Chemical Neuroscience: Mescaline. · ACS chemical neuroscience
- 2.PMID: 18720674 (2008) — Ecstasy analogues found in cacti. · Journal of psychoactive drugs
- 3.PMID: 36844095 (2023) — Natural or artificial: An example of topographic spatial distribution analysis of mescaline in cactus plants by matrix-assisted laser desorption/ionization mass spectrometry imaging. · Frontiers in plant science
- 4.PMID: 7412332 (1980) — Plant hallucinogens, shamanism and Nazca ceramics. · Journal of ethnopharmacology
- 5.PMID: 25821084 (2015) — A cactus-derived toxin-like cystine knot Peptide with selective antimicrobial activity.